Charles Schwab Investment Management Inc. Acquires 16,616 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Charles Schwab Investment Management Inc. raised its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 1.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,191,677 shares of the company's stock after purchasing an additional 16,616 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.96% of Henry Schein worth $82,464,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the company. ING Groep NV acquired a new stake in Henry Schein in the 3rd quarter valued at $63,226,000. Holocene Advisors LP acquired a new stake in Henry Schein during the 3rd quarter worth approximately $58,319,000. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of Henry Schein in the third quarter valued at about $43,740,000. Southpoint Capital Advisors LP lifted its position in shares of Henry Schein by 30.0% in the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company's stock worth $189,540,000 after purchasing an additional 600,000 shares in the last quarter. Finally, Bank of Montreal Can boosted its stake in shares of Henry Schein by 365.6% during the 3rd quarter. Bank of Montreal Can now owns 711,487 shares of the company's stock worth $52,095,000 after buying an additional 558,689 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

Analysts Set New Price Targets

HSIC has been the topic of several research analyst reports. UBS Group dropped their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 26th. Mizuho initiated coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price objective for the company. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and lifted their price target for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Wells Fargo & Company began coverage on Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price for the company. Finally, Barrington Research reiterated an "outperform" rating and set a $90.00 price objective on shares of Henry Schein in a research report on Wednesday, February 26th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Henry Schein currently has an average rating of "Moderate Buy" and a consensus target price of $81.10.

Remove Ads

Henry Schein Stock Performance

Shares of HSIC traded up $0.77 during mid-day trading on Friday, hitting $70.58. 1,443,065 shares of the company traded hands, compared to its average volume of 1,502,346. The stock has a 50-day moving average price of $74.81 and a two-hundred day moving average price of $72.60. The stock has a market cap of $8.76 billion, a price-to-earnings ratio of 29.05, a P/E/G ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter last year, the firm posted $0.66 earnings per share. The company's revenue was up 5.8% compared to the same quarter last year. Equities analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.